Patent details

EP1443967 Title: CYCLOOXYGENASE-2 INHIBITOR/HISTONE DEACETYLASE INHIBITOR COMBINATION

Basic Information

Publication number:
EP1443967
PCT Application Number:
PCT/EP/2002/012343
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027875723
PCT Publication Number:
WO/2003/039599
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CYCLOOXYGENASE-2 INHIBITOR/HISTONE DEACETYLASE INHIBITOR COMBINATION
French Title of Invention:
COMBINAISON D'INHIBITEUR DE CYCLOOXIGENASE-2 /INHIBITEUR D'HISTONE DESACETYLASE
German Title of Invention:
KOMBINATION CYCLOOXYGENASE-2 INHIBITOR/ HISTONE DEACETYLASE INHIBITOR
SPC Number:

Dates

Filing date:
05/11/2002
Grant date:
24/01/2007
EP Publication Date:
24/01/2007
PCT Publication Date:
15/05/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/08/2004
EP B1 Publication Date:
24/01/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/11/2011
Expiration date:
05/11/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/11/2002
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:
Novartis Pharma GmbH
Address:
Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:
LASSOTA Peter
Address:
United States (US)

2

Name:
CHEN Ying-Nan, Pan
Address:
United States (US)

3

Name:
WOOD Alexander, Wallace
Address:
United States (US)

Priority

1

Priority Number:
333016 P
Priority Date:
06/11/2001
Priority Country:
United States (US)

2

Priority Number:
419314 P
Priority Date:
17/10/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 45/06;
Filing date Document type Number of pages